A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
Part of paid clinical trials in Morton Grove, Illinois.
- Sponsor
- Stryker Trauma and Extremities
- Study ID
- NCT07118501
- Status
- Recruiting
Conditions
- Osteoarthritis
- Post Traumatic Arthritis
- Total Ankle Prosthesis
- Total Ankle Replacement
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Total Ankle Replacement — DEVICEIncompass™ Total Ankle System
Study Details
The goal of this study is to demonstrate the safety and performance of the Incompass™ Total Ankle System after surgery over the standard follow-up period. The study will measure improvements in patient-reported information related to quality of life and pain following surgery. In order to do this, medical imaging (i.e. X-Rays, CT scans) which have been taken as part of routine care, will be reviewed. Any additional X-Rays conducted during the period of the research will also be reviewed. The Incompass™ Total Ankle System has been cleared by the Food and Drug Administration (FDA). The products are already in use routinely in ankle replacement surgeries. No part of this study is experimental.
Key Dates
- Start date
- Feb 6, 2026
- Status verified
- Mar 2026
- Primary completion
- Sep 30, 2030
- Completion
- Sep 1, 2038
Study Design
- Enrollment
- 200 participants (estimated)
Arms
- Arm: Incompass™ Total Ankle SystemPrimary Total Ankle Replacement using the Incompass™ Total Ankle System
Primary Outcome Measure
Ankle Osteoarthritis Scale (AOS) [ Time Frame: Baseline, 6 month, 1 Year, 2 Year, 5 Year, 7 Year, 10 Year ]
Central Contacts
- Caryn Thompson704-891-6540
- Rebecca Gibson
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Illinois Bone and Joint Institute | Morton Grove | Illinois | 60053 | Daisy Zarco Brian Weatherford, MD (PRINCIPAL_INVESTIGATOR) |
| Baptist Health Louisville | Louisville | Kentucky | 40207 | Karin Cryan, BSN RN CCRP John S Lewis, Jr, MD (PRINCIPAL_INVESTIGATOR) |
| Slocum Research & Education Foundation | Eugene | Oregon | 97401 | Hannah College Lyle Jackson, MD (PRINCIPAL_INVESTIGATOR) |
| MUSC | Charleston | South Carolina | 29425 | Christopher Gross, MD (PRINCIPAL_INVESTIGATOR) Daniel Scott, MD (SUB_INVESTIGATOR) |
Find similar trials in Morton Grove, IL
Related Studies
- Dose Response of Exercise for Arthritis ManagementRecruiting · University of South Carolina · Columbia, South Carolina
- A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the KneePHASE3 · Recruiting · Eli Lilly and Company · Phoenix, Arizona
- Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightPHASE3 · Recruiting · Eli Lilly and Company · Mobile, Alabama
- Genicular Artery Embolization for Knee OsteoarthritisRecruiting · Northwestern University · Chicago, Illinois